Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Sun Pharmaceutical Industries has lined up 11 banks, including State Bank of India (SBI), to finance its $11.75 billion ...

The brokerage expects domestic-focused pharma companies to outperform peers exposed to high-value US generic opportunities, ...

Sushil Kedia viewing the current uncertainty and volatility in US indices maintains that it will be no surprise if Nifty ...

In the Asian market today, Japans Nikkei extended its climb past the 68,000 mark, offering support for Indian equities in ...

AstraZeneca will continue to hold the intellectual property, manage the import licence, and retain the Marketing Authorisation for the drug.

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Stock of Sun Pharmaceutical is in focus as the company’s shares are set to turn ex- dividend tomorrow with its final dividend ...

Those who allege fraud must prove it — affirmatively, and to a standard higher than the ordinary balance of probabilities. The petitioners, ...

Delhi High Court restrained Finecure Pharmaceuticals from manufacturing drugs similar to Sun Pharma's 'Pantocid,' allowing limited time to sell existing 'Pantopacid' stock.

Pharma stocks are grabbing attention due to strong healthcare demand, rising global medicine need and increasing exports.